The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.
about
Spectroscopic characterization and crystal structures of two cathinone derivatives: N-ethyl-2-amino-1-phenylpropan-1-one (ethcathinone) hydrochloride and N-ethyl-2-amino-1-(4-chlorophenyl)propan-1-one (4-CEC) hydrochlorideFocus on cannabinoids and synthetic cannabinoids.Simultaneous identification and quantification of new psychoactive substances in blood by GC-APCI-QTOFMS coupled to nitrogen chemiluminescence detection without authentic reference standards.Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA.Correlation between blood and oral fluid psychoactive drug concentrations and cognitive impairment in Driving Under the Influence of Drugs.Synthetic cathinones in Southern Germany - characteristics of users, substance-patterns, co-ingestions, and complications.Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control study.Confirmation of Carfentanil, U-47700 and Other Synthetic Opioids in a Human Performance Case by LC-MS-MS.Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population.Spectroscopic and crystallographic characterization of two cathinone derivatives: 1-(4-fluorophenyl)-2-(methylamino)pentan-1-one (4-FPD) hydrochloride and 1-(4-methylphenyl)-2-(ethylamino)pentan-1-one (4-MEAP) hydrochloride.Stability of Synthetic Cathinones in Blood.Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine.Gestational Exposure to the Synthetic Cathinone Methylenedioxypyrovalerone Results in Reduced Maternal Care and Behavioral Alterations in Mouse Pups.
P2860
Q28818021-51FC7973-61ED-4BF8-9667-18DE563A6EC9Q30241053-32121950-9074-46E6-8A14-B81F0B01DB05Q33467435-E08BD7BF-7D89-431A-9364-0C678BC21AD4Q34528325-EE1D102A-5F0D-42D7-AF93-33C1228F4BDAQ38605437-F47AB053-6135-4580-90B9-4368DF1DA31AQ38873513-32D36F0F-041D-49ED-B5BF-253EC5584AC8Q39604084-CC46416A-A27A-4D62-86AB-DCBB04647C2CQ44346648-AE571186-5A85-4D01-9502-D34F046AABB5Q47260828-C654E677-6C00-44EC-9ED0-EEF507C9EAC3Q47647717-9D56BBD2-A7B5-4BC6-8D03-EFAD078D7260Q48235317-9E4CC48D-FF3C-4662-96C6-2BACB4A14722Q49265185-36EC27C5-7952-4956-A85D-3EC819AA2D75Q49607383-D7F74B7D-2349-4847-854F-C195B9177CAAQ49628077-73DD71D9-F5C0-459E-99D5-838F40591255Q50074132-C3DEBC92-1A1B-4092-B48E-1912F99D54D3
P2860
The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The prevalence of new psychoac ...... review of casework in Poland.
@en
type
label
The prevalence of new psychoac ...... review of casework in Poland.
@en
prefLabel
The prevalence of new psychoac ...... review of casework in Poland.
@en
P2093
P2860
P356
P1476
The prevalence of new psychoac ...... review of casework in Poland.
@en
P2093
Agnieszka Skulska
Bogdan Tokarczyk
Dominika Gil
Joanna Gieroń
Piotr Adamowicz
Wojciech Lechowicz
P2860
P356
10.1002/DTA.1924
P577
2015-12-14T00:00:00Z